Absorption |
Blood-Brain Barrier | BBB+ | 0.9832 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8394 |
P-glycoprotein Substrate | Non-substrate | 0.8101 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9219 |
Non-inhibitor | 0.9311 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8241 |
Distribution |
Subcellular localization | Mitochondria | 0.6948 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8318 |
CYP450 2D6 Substrate | Non-substrate | 0.8203 |
CYP450 3A4 Substrate | Non-substrate | 0.7352 |
CYP450 1A2 Inhibitor | Inhibitor | 0.8531 |
CYP450 2C9 Inhibitor | Inhibitor | 0.5518 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9529 |
CYP450 2C19 Inhibitor | Inhibitor | 0.6241 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9172 |
CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.6942 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9663 |
Non-inhibitor | 0.8452 |
AMES Toxicity | Non AMES toxic | 0.9132 |
Carcinogens | Non-carcinogens | 0.5485 |
Fish Toxicity | High FHMT | 0.9900 |
Tetrahymena Pyriformis Toxicity | High TPT | 1.0000 |
Honey Bee Toxicity | High HBT | 0.7101 |
Biodegradation | Not ready biodegradable | 0.9666 |
Acute Oral Toxicity | III | 0.7103 |
Carcinogenicity (Three-class) | Non-required | 0.4547 |